Revance Therapeutics, Inc. (RVNC)
USD 3.65
(0.0%)
USD 3.65
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 340.55 Million USD | 10.03% |
| 2022 | 309.5 Million USD | 44.7% |
| 2021 | 213.88 Million USD | 276.11% |
| 2020 | -121.44 Million USD | 14.36% |
| 2019 | -141.82 Million USD | -93.6% |
| 2018 | -73.25 Million USD | 73.93% |
| 2017 | -281.02 Million USD | -383.23% |
| 2016 | -58.15 Million USD | 69.89% |
| 2015 | -193.13 Million USD | -15.31% |
| 2014 | -167.49 Million USD | -876.07% |
| 2013 | 21.58 Million USD | -78.92% |
| 2012 | 102.36 Million USD | 160.04% |
| 2011 | 39.36 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 342.61 Million USD | 0.61% |
| 2024 Q2 | 409.9 Million USD | 19.64% |
| 2023 Q2 | 291.15 Million USD | -2.64% |
| 2023 Q1 | 299.04 Million USD | -3.38% |
| 2023 Q4 | 340.55 Million USD | 10.36% |
| 2023 FY | 340.55 Million USD | 10.03% |
| 2023 Q3 | 308.58 Million USD | 5.99% |
| 2022 Q1 | 294.11 Million USD | 37.51% |
| 2022 Q2 | 368.27 Million USD | 25.21% |
| 2022 FY | 309.5 Million USD | 44.7% |
| 2022 Q4 | 309.5 Million USD | -4.3% |
| 2022 Q3 | 323.41 Million USD | -12.18% |
| 2021 FY | 213.88 Million USD | 276.11% |
| 2021 Q4 | 213.88 Million USD | 7.79% |
| 2021 Q1 | 60.94 Million USD | 150.18% |
| 2021 Q3 | 198.43 Million USD | 24.58% |
| 2021 Q2 | 159.29 Million USD | 161.39% |
| 2020 Q2 | -161.54 Million USD | -86.06% |
| 2020 Q1 | -86.82 Million USD | 38.78% |
| 2020 FY | -121.44 Million USD | 14.36% |
| 2020 Q3 | -134.56 Million USD | 16.7% |
| 2020 Q4 | -121.44 Million USD | 9.75% |
| 2019 FY | -141.82 Million USD | -93.6% |
| 2019 Q4 | -141.82 Million USD | -391.97% |
| 2019 Q3 | -28.82 Million USD | 51.31% |
| 2019 Q1 | -33.74 Million USD | 53.94% |
| 2019 Q2 | -59.2 Million USD | -75.46% |
| 2018 Q3 | -45.13 Million USD | -14.89% |
| 2018 FY | -73.25 Million USD | 73.93% |
| 2018 Q4 | -73.25 Million USD | -62.31% |
| 2018 Q2 | -39.28 Million USD | 42.43% |
| 2018 Q1 | -68.22 Million USD | 75.72% |
| 2017 Q1 | -33.75 Million USD | 41.97% |
| 2017 Q2 | -50.14 Million USD | -48.57% |
| 2017 Q3 | -53.59 Million USD | -6.89% |
| 2017 Q4 | -281.02 Million USD | -424.34% |
| 2017 FY | -281.02 Million USD | -383.23% |
| 2016 Q4 | -58.15 Million USD | 53.22% |
| 2016 Q2 | -45.67 Million USD | -38.2% |
| 2016 Q3 | -124.3 Million USD | -172.14% |
| 2016 Q1 | -33.05 Million USD | 82.89% |
| 2016 FY | -58.15 Million USD | 69.89% |
| 2015 Q4 | -193.13 Million USD | -137.56% |
| 2015 Q2 | -86.53 Million USD | 43.4% |
| 2015 FY | -193.13 Million USD | -15.31% |
| 2015 Q1 | -152.88 Million USD | 8.72% |
| 2015 Q3 | -81.3 Million USD | 6.05% |
| 2014 Q3 | -177.78 Million USD | 7.19% |
| 2014 Q1 | -74.04 Million USD | -443.1% |
| 2014 FY | -167.49 Million USD | -876.07% |
| 2014 Q4 | -167.49 Million USD | 5.79% |
| 2014 Q2 | -191.56 Million USD | -158.7% |
| 2013 Q4 | 21.58 Million USD | 93.27% |
| 2013 Q3 | 11.16 Million USD | 0.0% |
| 2013 Q1 | -10.19 Million USD | -109.96% |
| 2013 FY | 21.58 Million USD | -78.92% |
| 2012 FY | 102.36 Million USD | 160.04% |
| 2012 Q4 | 102.36 Million USD | 0.0% |
| 2011 FY | 39.36 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 708.786% |
| Alkermes plc | -166.73 Million USD | 304.244% |
| Agenus Inc. | 274.13 Million USD | -24.228% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 81.788% |
| Aptorum Group Limited | 1.35 Million USD | -24995.317% |
| Ardelyx, Inc. | 34.51 Million USD | -886.773% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -7856.893% |
| Bicycle Therapeutics plc | -481.46 Million USD | 170.733% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -841.722% |
| ChromaDex Corporation | -24.04 Million USD | 1516.147% |
| Chimerix, Inc. | -25.51 Million USD | 1434.62% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -4787.361% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 1538.337% |
| CRISPR Therapeutics AG | -150.84 Million USD | 325.765% |
| Precision BioSciences, Inc. | -85.41 Million USD | 498.73% |
| Dyadic International, Inc. | -6.37 Million USD | 5439.444% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 2237.419% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4342.988% |
| Lantern Pharma Inc. | -21.7 Million USD | 1669.141% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 408.091% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 4086.281% |
| Incyte Corporation | -3.17 Billion USD | 110.726% |
| IO Biotech, Inc. | -140.69 Million USD | 342.045% |
| Jaguar Health, Inc. | 29.39 Million USD | -1058.705% |
| Novavax, Inc. | -298.29 Million USD | 214.168% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -6281.019% |
| Opthea Limited | 28.15 Million USD | -1109.467% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 2128.441% |
| ContextLogic Inc. | -232 Million USD | 246.791% |
| MiMedx Group, Inc. | -33.9 Million USD | 1104.557% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -3240.412% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 14797.93% |
| NextCure, Inc. | -6.47 Million USD | 5357.913% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 774.353% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 5438.689% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -2699.865% |
| Vaxcyte, Inc. | -368.22 Million USD | 192.485% |
| PDS Biotechnology Corporation | -32.7 Million USD | 1141.169% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -1871.033% |
| Pharming Group N.V. | 109.8 Million USD | -210.148% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 2057.663% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 294.347% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1938.864% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1938.864% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 4896.549% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 5911.519% |
| Acelyrin, Inc. | -216.9 Million USD | 257.008% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 6170.21% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 19853.77% |
| Summit Therapeutics Inc. | 34.67 Million USD | -882.162% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 5105.953% |
| Senti Biosciences, Inc. | 1.74 Million USD | -19472.126% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 284.476% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 539.704% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 5717.865% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -341243.503% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -54128.503% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 390.958% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 302.431% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -207.166% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 4583.346% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 363.763% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -4839.447% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 240.514% |
| Immix Biopharma, Inc. | -17.5 Million USD | 2044.94% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 207.531% |
| MEI Pharma, Inc. | -3.7 Million USD | 9291.768% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -2622.045% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -110.554% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -1125.327% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4342.988% |
| Precigen, Inc. | -481 Thousand USD | 70901.455% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -2318.543% |
| AlloVir, Inc. | -62.69 Million USD | 643.219% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 712.355% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -452.257% |
| ImmuCell Corporation | 10.99 Million USD | -2998.613% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 320.93% |
| Onconetix, Inc. | 5.33 Million USD | -6287.677% |
| PureTech Health plc | -167.19 Million USD | 303.685% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 1218.04% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1881.332% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 7037.36% |
| Seer, Inc. | -4.24 Million USD | 8131.958% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1516.795% |
| Innoviva, Inc. | 255.56 Million USD | -33.257% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 709.614% |
| ESSA Pharma Inc. | -33.62 Million USD | 1112.906% |
| GlycoMimetics, Inc. | -40.98 Million USD | 930.938% |
| GT Biopharma, Inc. | -1.02 Million USD | 33455.044% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 602.419% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -455.945% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 353.996% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 2557.816% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 1279.534% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 452160.159% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 1203.477% |
| Aptose Biosciences Inc. | -8.19 Million USD | 4255.716% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 10983.766% |
| Soligenix, Inc. | -4.95 Million USD | 6977.68% |
| Century Therapeutics, Inc. | 847 Thousand USD | -40107.202% |
| Kura Oncology, Inc. | -20.11 Million USD | 1792.788% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 932.124% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 4155.192% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -18594.403% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 10752.33% |
| Autolus Therapeutics plc | -186.59 Million USD | 282.506% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 790.725% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 223.482% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -893.799% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -107.191% |
| GRI Bio, Inc. | -1.79 Million USD | 19082.999% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 3891.086% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 1124.01% |
| IGM Biosciences, Inc. | -72.6 Million USD | 569.045% |
| INmune Bio, Inc. | -25.41 Million USD | 1440.187% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -125.606% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 772.25% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2195.804% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 11904.636% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -795.844% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 926.891% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -968.073% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 9.894% |
| Verastem, Inc. | -37.27 Million USD | 1013.555% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 3853.499% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 756.656% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 2350.116% |
| Histogen Inc. | -7.48 Million USD | 4648.618% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1676.146% |
| Surrozen, Inc. | -32.66 Million USD | 1142.6% |
| Organovo Holdings, Inc. | -1.5 Million USD | 22698.208% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 8201.724% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1696.156% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -12918.157% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -8094.297% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 4163.345% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 883.93% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 2436.271% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 207.502% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 47264.363% |
| Apollomics, Inc. | -27.39 Million USD | 1343.128% |
| Amarin Corporation plc | -191.04 Million USD | 278.264% |
| Mesoblast Limited | 55.96 Million USD | -508.536% |
| Turnstone Biologics Corp. | -14.58 Million USD | 2435.128% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 1446.493% |
| Synaptogenix, Inc. | -28.66 Million USD | 1288.197% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 36484.081% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -598.832% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 39603.462% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 4786.915% |
| Exelixis, Inc. | -73.05 Million USD | 566.194% |
| Better Therapeutics, Inc. | -860 Thousand USD | 39699.419% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1518.211% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 241.092% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -46166.911% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 4678.5% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -27057.496% |
| Gritstone bio, Inc. | 39.49 Million USD | -762.383% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 504.936% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 13038.332% |
| Avid Bioservices, Inc. | 169.72 Million USD | -100.648% |
| Insmed Incorporated | 721.62 Million USD | 52.807% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 3825.368% |
| MediWound Ltd. | -5.32 Million USD | 6499.004% |
| OmniAb, Inc. | 9.2 Million USD | -3600.478% |
| Alector, Inc. | -35.63 Million USD | 1055.622% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -296.128% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 7010.613% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -2472.362% |
| Zai Lab Limited | -775 Million USD | 143.943% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1682.137% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 512.894% |
| Immunic, Inc. | -45.34 Million USD | 851.114% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 276.257% |
| Veracyte, Inc. | -203.82 Million USD | 267.083% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 46.646% |
| FibroGen, Inc. | 56.76 Million USD | -499.917% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3724.312% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 12146.166% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 16549.167% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 92.581% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 10293.206% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 305.198% |
| TG Therapeutics, Inc. | 17.86 Million USD | -1806.589% |
| Galecto, Inc. | -21.21 Million USD | 1705.18% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1531.806% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 78.3% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1491.611% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 3059.546% |
| XBiotech Inc. | -200.02 Million USD | 270.258% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 504.936% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -7421.091% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1065.757% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 541.031% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -5884.098% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 299.839% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 468.67% |
| Vaxxinity, Inc. | 10.13 Million USD | -3261.182% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 53.746% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 3262.79% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 616.337% |
| NexImmune, Inc. | -3.13 Million USD | 10967.703% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 9963.517% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 2353.622% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 1356.661% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 3894.04% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 273473.47% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 939.384% |
| Ainos, Inc. | 4.07 Million USD | -8251.177% |
| Pluri Inc. | 22.82 Million USD | -1391.765% |
| Prothena Corporation plc | -608.34 Million USD | 155.98% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 386.769% |
| Celularity Inc. | 65.19 Million USD | -422.404% |
| Rallybio Corporation | -24.1 Million USD | 1512.974% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1106.993% |
| MeiraGTx Holdings plc | -40.3 Million USD | 945.008% |
| Omeros Corporation | 331.17 Million USD | -2.832% |
| Humacyte, Inc. | -22.48 Million USD | 1614.52% |
| Immunocore Holdings plc | -358.59 Million USD | 194.97% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1485.778% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 1202.084% |
| Blueprint Medicines Corporation | 702.83 Million USD | 51.546% |
| CalciMedica, Inc. | -5.53 Million USD | 6258.318% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 280.935% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 3434.198% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 950.601% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 1124.133% |
| Pulmatrix, Inc. | -10.41 Million USD | 3369.223% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 5797.758% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 992.861% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 405.699% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 668.122% |
| Cytokinetics, Incorporated | 642.37 Million USD | 46.985% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 5948.446% |
| Nutriband Inc. | -251.65 Thousand USD | 135425.065% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1098.139% |
| Vor Biopharma Inc. | 4.3 Million USD | -7819.884% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 105.642% |
| Evogene Ltd. | -19.63 Million USD | 1834.517% |
| ProKidney Corp. | -56.23 Million USD | 705.582% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 799.694% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 3786.783% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 75.031% |
| CorMedix Inc. | -43.05 Million USD | 891.022% |
| BioLineRx Ltd. | 7.33 Million USD | -4542.244% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 1339.96% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -637.979% |
| Atai Life Sciences N.V. | -28.55 Million USD | 1292.503% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -15167.903% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1592.615% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -1820.242% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 553.626% |
| MediciNova, Inc. | -50.78 Million USD | 770.601% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 532.149% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1514014.203% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5377.804% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 270.43% |
| Biomea Fusion, Inc. | -166.57 Million USD | 304.452% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 290.281% |
| Mereo BioPharma Group plc | -51.46 Million USD | 761.67% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 459.069% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 215.93% |
| Absci Corporation | -72.59 Million USD | 569.097% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7358.498% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 245.265% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 461.481% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 455.872% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 971.587% |
| Allakos Inc. | -24.97 Million USD | 1463.584% |
| Imunon, Inc. | -4.21 Million USD | 8181.798% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 2410.1% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 351.518% |
| BioAtla, Inc. | -109.01 Million USD | 412.404% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -46166.911% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 36367.838% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -2746.022% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1706.164% |
| XOMA Corporation | -29 Million USD | 1274.328% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 2156.492% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 3877.229% |
| aTyr Pharma, Inc. | -7.44 Million USD | 4671.822% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 373.24% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 263.599% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 516.433% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 467.124% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 39737.028% |
| Akari Therapeutics, Plc | -3.84 Million USD | 8957.087% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -20884.478% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 75.338% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 28762.989% |
| UroGen Pharma Ltd. | 4.39 Million USD | -7655.75% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -200.099% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -473142.823% |
| Orgenesis Inc. | 21.78 Million USD | -1463.326% |
| Entera Bio Ltd. | -10.62 Million USD | 3304.017% |
| GH Research PLC | -78.07 Million USD | 536.178% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1627.975% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 1377.449% |
| Xencor, Inc. | 29.64 Million USD | -1048.816% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 17388.706% |
| Replimune Group, Inc. | 1.41 Million USD | -24018.626% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 139154.257% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 369.39% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 28762.989% |
| Portage Biotech Inc. | -4.98 Million USD | 6937.081% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1514014.203% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 615.04% |
| OncoCyte Corporation | -6.56 Million USD | 5289.014% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -37848.525% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 7575.454% |
| Purple Biotech Ltd. | -14.13 Million USD | 2508.792% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1533.554% |
| scPharmaceuticals Inc. | -6.54 Million USD | 5303.285% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 2140.209% |
| HilleVax, Inc. | -165.48 Million USD | 305.792% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 13518.243% |
| Tharimmune, Inc. | -10.93 Million USD | 3214.257% |
| Genprex, Inc. | -6.73 Million USD | 5154.523% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 192.34% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 484.982% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 24407.994% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 10367.125% |
| OKYO Pharma Limited | -826.84 Thousand USD | 41287.135% |
| Savara Inc. | 153 Thousand USD | -222484.967% |
| Curis, Inc. | -23.88 Million USD | 1525.692% |
| Daré Bioscience, Inc. | -5.15 Million USD | 6702.576% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 43985.275% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 5585.744% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -28638.819% |
| BeiGene, Ltd. | -2.25 Billion USD | 115.115% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -2660.1% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 155.994% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 283.503% |
| Erasca, Inc. | -37.21 Million USD | 1015.077% |
| bluebird bio, Inc. | 108.57 Million USD | -213.67% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 26542.802% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 10.084% |
| DBV Technologies S.A. | -126.98 Million USD | 368.183% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 26542.802% |
| Moderna, Inc. | -2.9 Billion USD | 111.715% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 3389.751% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 3233.557% |
| Molecular Templates, Inc. | 707 Thousand USD | -48069.024% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 1185.573% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 1.746% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 514.997% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 471.258% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 1155.265% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1090.677% |
| MacroGenics, Inc. | -66.98 Million USD | 608.405% |
| RenovoRx, Inc. | -1.17 Million USD | 29132.822% |
| Adicet Bio, Inc. | -138.78 Million USD | 345.38% |
| Prime Medicine, Inc. | -27.94 Million USD | 1318.836% |
| Aditxt, Inc. | 18.12 Million USD | -1779.351% |
| Adagene Inc. | -87.62 Million USD | 488.64% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8275.75% |
| Quantum-Si incorporated | -118.55 Million USD | 387.25% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -845.855% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 4656.415% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 802.045% |
| SciSparc Ltd. | -2.06 Million USD | 16591.768% |
| Vericel Corporation | 1.27 Million USD | -26568.363% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2939.922% |
| Minerva Neurosciences, Inc. | 41 Million USD | -730.536% |
| Generation Bio Co. | 31.44 Million USD | -982.915% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 294.199% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 1201.3% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -192.089% |
| Invivyd, Inc. | -198.47 Million USD | 271.585% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 477.263% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 14303.473% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 581.078% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 5089.817% |
| 2seventy bio, Inc. | 181.71 Million USD | -87.412% |
| ADMA Biologics, Inc. | 90.06 Million USD | -278.117% |
| Clene Inc. | 3.34 Million USD | -10096.257% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 3849.49% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1683.167% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5377.804% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 198.963% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 1409.843% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -91.683% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 8423.339% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -6708.377% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 6637.819% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 361.354% |
| Evaxion Biotech A/S | 5.28 Million USD | -6341.556% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 402.533% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 359.425% |
| Trevena, Inc. | 2.25 Million USD | -14982.152% |
| Surrozen, Inc. | -32.66 Million USD | 1142.6% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 761.143% |
| Cingulate Inc. | 3.08 Million USD | -10947.357% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 11695.335% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -4638.486% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 3765.339% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 529.327% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 359.072% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 422.672% |
| Clearmind Medicine Inc. | -3.94 Million USD | 8737.747% |
| Kronos Bio, Inc. | -36.05 Million USD | 1044.569% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -3519.46% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -23255.647% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 727.682% |
| Statera Biopharma, Inc. | 14.41 Million USD | -2262.274% |
| ImmunityBio, Inc. | 618.22 Million USD | 44.914% |
| Korro Bio, Inc. | -132.94 Million USD | 356.166% |
| Kineta, Inc. | -4.54 Million USD | 7599.56% |
| BioVie Inc. | -17.73 Million USD | 2020.529% |
| Codexis, Inc. | -43.27 Million USD | 887.028% |
| Celularity Inc. | 65.19 Million USD | -422.404% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 10846.45% |
| Celcuity Inc. | 6.78 Million USD | -4920.337% |
| Virax Biolabs Group Limited | -3.36 Million USD | 10220.674% |
| Cibus, Inc. | -8.07 Million USD | 4315.833% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 8152.849% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -7351.969% |
| IN8bio, Inc. | -16.38 Million USD | 2177.949% |
| Kodiak Sciences Inc. | -103.87 Million USD | 427.851% |
| Annexon, Inc. | -193.75 Million USD | 275.766% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -945886.111% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 2046.14% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 9794.136% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 67.698% |
| Eyenovia, Inc. | 1.25 Million USD | -26956.047% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -1165.768% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10601.233% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 1124.318% |
| Arcellx, Inc. | -296.95 Million USD | 214.681% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1845.899% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 678.437% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1743.05% |
| Moolec Science SA | 117.61 Thousand USD | -289448.191% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 986.885% |
| Geron Corporation | 14.76 Million USD | -2207.127% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 998.135% |
| Royalty Pharma plc | 5.65 Billion USD | 93.981% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 340.809% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 4972.433% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 6450.251% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 341.99% |
| Humacyte, Inc. | -22.48 Million USD | 1614.52% |
| Structure Therapeutics Inc. | -124.33 Million USD | 373.892% |
| 89bio, Inc. | -289.05 Million USD | 217.817% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 1449.16% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 19200.112% |
| Genelux Corporation | -6.89 Million USD | 5036.295% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 1196.478% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -307.367% |
| Notable Labs, Ltd. | -9.77 Million USD | 3583.582% |
| Liquidia Corporation | -80.17 Million USD | 524.759% |
| Mustang Bio, Inc. | -3.73 Million USD | 9215.498% |
| Immunovant, Inc. | -635.22 Million USD | 153.612% |
| Quantum-Si incorporated | -118.55 Million USD | 387.25% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 2038.938% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 8320.01% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -4142.619% |
| Acasti Pharma Inc. | -23 Million USD | 1580.352% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 10213.806% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2195.804% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 347.245% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 11027.967% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1631.823% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1933.998% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 301.181% |
| PepGen Inc. | -60.67 Million USD | 661.324% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1582.221% |
| United Therapeutics Corporation | -507.7 Million USD | 167.078% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1880.587% |
| Solid Biosciences Inc. | -47.75 Million USD | 813.204% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 39603.462% |
| Immuneering Corporation | -54.94 Million USD | 719.835% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 8201.724% |
| Silo Pharma, Inc. | -3.52 Million USD | 9763.032% |
| Belite Bio, Inc | -87.27 Million USD | 490.227% |
| XOMA Corporation | -29 Million USD | 1274.328% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 581.711% |
| Bionomics Limited | 227 Million USD | -50.018% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 392.87% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13544.73% |
| uniQure N.V. | -102.95 Million USD | 430.793% |
| Cassava Sciences, Inc. | -121.13 Million USD | 381.134% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8275.75% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -731.616% |
| Forte Biosciences, Inc. | -11.96 Million USD | 2947.212% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 11106.237% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -321178.302% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10601.233% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3724.312% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 4692.166% |
| Altimmune, Inc. | -134.48 Million USD | 353.225% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -71.941% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13544.73% |
| Compugen Ltd. | -12.9 Million USD | 2739.143% |
| Peak Bio, Inc. | 10.34 Million USD | -3193.518% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 120437.456% |
| Benitec Biopharma Inc. | -50.58 Million USD | 773.273% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 426.396% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1633.545% |
| Zura Bio Limited | -99.8 Million USD | 441.217% |
| PolyPid Ltd. | 6.17 Million USD | -5419.53% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -359.464% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1633.545% |
| Instil Bio, Inc. | 75.35 Million USD | -351.916% |
| argenx SE | -2.02 Billion USD | 116.786% |
| Immunome, Inc. | -97.02 Million USD | 450.983% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1613.914% |
| Verona Pharma plc | -220.44 Million USD | 254.487% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 574.687% |
| Shattuck Labs, Inc. | -121.42 Million USD | 380.468% |
| CervoMed Inc. | -7.79 Million USD | 4470.098% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 283.589% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 7887.674% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 358.505% |
| Moolec Science SA | 117.61 Thousand USD | -289448.191% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 14984.546% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -2042.074% |
| AnaptysBio, Inc. | -18.15 Million USD | 1976.233% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1976.336% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 583.873% |
| NeurAxis, Inc. | 145.7 Thousand USD | -233637.131% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -2932.007% |
| Lumos Pharma, Inc. | -28.49 Million USD | 1295.223% |
| Achilles Therapeutics plc | -126.92 Million USD | 368.314% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 574.687% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 52035.248% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1739.347% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -23255.647% |
| Nutriband Inc. | -251.65 Thousand USD | 135425.065% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 2685.643% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 4677.352% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -0.105% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -1334.822% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 176.107% |
| Palisade Bio, Inc. | -12.06 Million USD | 2923.137% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 342.714% |
| Beam Therapeutics Inc. | -262.72 Million USD | 229.626% |
| Neurogene Inc. | -131.95 Million USD | 358.084% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -1461.033% |
| AEON Biopharma, Inc. | -4.88 Million USD | 7078.586% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 190.287% |
| Sesen Bio, Inc. | -112.55 Million USD | 402.573% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 441.032% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 14605.325% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 972.636% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 508.918% |
| Athira Pharma, Inc. | -88.99 Million USD | 482.65% |
| Vaccinex, Inc. | -1.28 Million USD | 26540.606% |
| HCW Biologics Inc. | 2.85 Million USD | -11821.373% |
| XOMA Corporation | -29 Million USD | 1274.328% |
| Nektar Therapeutics | 210.24 Million USD | -61.984% |
| Arvinas, Inc. | -313.8 Million USD | 208.526% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -20884.478% |
| Merus N.V. | -192.88 Million USD | 276.559% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -467.734% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 5008.547% |
| Rezolute, Inc. | -68.16 Million USD | 599.582% |
| Clene Inc. | 3.34 Million USD | -10096.257% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 2682.505% |
| BeyondSpring Inc. | -13.75 Million USD | 2575.863% |
| Synlogic, Inc. | -6.68 Million USD | 5194.316% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -29931.305% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 4127.853% |
| Peak Bio, Inc. | 10.34 Million USD | -3193.518% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 513.195% |
| Krystal Biotech, Inc. | -350.23 Million USD | 197.236% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -174.365% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 301.517% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 10886.806% |
| MannKind Corporation | 143.89 Million USD | -136.663% |
| Ikena Oncology, Inc. | -109.15 Million USD | 411.989% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 4598.151% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 1128.867% |
| Gossamer Bio, Inc. | 180.35 Million USD | -88.825% |
| CohBar, Inc. | -5.93 Million USD | 5842.21% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 1244.8% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7358.498% |
| Legend Biotech Corporation | -949.39 Million USD | 135.871% |
| Mural Oncology plc | -255.84 Million USD | 233.111% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -957.132% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 7329.482% |
| Disc Medicine, Inc. | -358.28 Million USD | 195.052% |
| Champions Oncology, Inc. | 4.81 Million USD | -6977.203% |
| REGENXBIO Inc. | 54.76 Million USD | -521.814% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 126744.156% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 325.497% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 3878.903% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 522.09% |
| Vaxart, Inc. | -8.24 Million USD | 4232.448% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 778.667% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 367.804% |
| Cellectis S.A. | -43.85 Million USD | 876.548% |
| Longeveron Inc. | -2.9 Million USD | 11810.97% |
| Repare Therapeutics Inc. | -107.85 Million USD | 415.744% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 64.832% |
| Inozyme Pharma, Inc. | 12 Million USD | -2737.013% |
| Revolution Medicines, Inc. | -608.2 Million USD | 155.994% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 27787.398% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 228.455% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 326.928% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 2276.488% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 46120.946% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 103.561% |
| Denali Therapeutics Inc. | -74.86 Million USD | 554.892% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2939.922% |
| Veru Inc. | 4.77 Million USD | -7024.628% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 3128.232% |
| Cingulate Inc. | 3.08 Million USD | -10947.357% |
| Passage Bio, Inc. | 4.58 Million USD | -7327.59% |
| Context Therapeutics Inc. | -14.44 Million USD | 2456.81% |
| Exicure, Inc. | 5.84 Million USD | -5722.448% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 247.826% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 960.639% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -2070.384% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 678.968% |
| Nuvalent, Inc. | -335.38 Million USD | 201.541% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -19535.989% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 557.231% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 3930.765% |
| OmniAb, Inc. | 9.2 Million USD | -3600.478% |
| Anew Medical, Inc. | 1.43 Million USD | -23674.054% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -1978.868% |
| Lipocine Inc. | -4.75 Million USD | 7262.655% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 410.08% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -2135.933% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 772.25% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -1268.13% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 5167.029% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 617.349% |
| Ocugen, Inc. | -32.52 Million USD | 1147.185% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 497.961% |
| Q32 Bio Inc. | -37.94 Million USD | 997.425% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 54328.503% |
| Alumis Inc. Common Stock | -13.52 Million USD | 2617.222% |
| Equillium, Inc. | -22.39 Million USD | 1620.878% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 1431.958% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 1143.79% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 137467.646% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -154.066% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -10548.999% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -103588.334% |
| Dominari Holdings Inc. | 195 Thousand USD | -174543.59% |
| Edesa Biotech, Inc. | -5.26 Million USD | 6565.935% |
| vTv Therapeutics Inc. | -8.91 Million USD | 3919.166% |
| Bio-Techne Corporation | 267.74 Million USD | -27.193% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 2201.024% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 388.376% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 4152.779% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 2791.922% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 238.935% |
| Nkarta, Inc. | 57.29 Million USD | -494.347% |
| BioCardia, Inc. | 212 Thousand USD | -160539.151% |
| Iterum Therapeutics plc | 13.43 Million USD | -2434.268% |